News | December 06, 2025
Briefs: IOL Chemicals & Pharmaceuticals, Ipca Laboratories and Anuh Pharma
Ipca Laboratories receives three observations from USFDA for API facility at Tarapur
Ipca Laboratories receives three observations from USFDA for API facility at Tarapur
Excelsior aims to make reshoring affordable and strategic, shielding nations from geopolitical disruptions
The FW500 is designed to meet the evolving needs of mid-sized diagnostic laboratories
Pantoprazole sodium is a proton pump inhibitor reduces stomach acid
Speakers for the Session are: Venkata Prasad K., Unit Head, Deepak Nitrite; Abhilash Pasham, Associate General Manager - Central Engineering & Projects, Dr. Reddy's Laboratories; C. V. Rajulu, Consultant, Industry; and Jyoti Shankar Jha, Senior Lead Scientist, Alleima India. The moderator for the Session is Pravin Prashant, Executive Editor, Indian Pharma Post
It represents a 30% increase in the company’s production capacity and introduces a segment dedicated to highly potent active ingredients
Products manufactured at the new Vaughan facility will support research in areas including cancer, infectious disease, mental health, and environmental safety
IOLCP has reported total income of Rs. 559.06 crores during the period ended June 30, 2025
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
Plant-based chemistries have an outsized role to play for the HPC sector by meeting demand for good, gentle, and green products
Subscribe To Our Newsletter & Stay Updated
